No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
1 | Arachidonic acid metabolism 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
2 | C-type lectin receptor signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
3 | Chemical carcinogenesis 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
4 | Cytokine-cytokine receptor interaction 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
5 | GABAergic synapse 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
6 | Hematopoietic cell lineage 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
7 | Human cytomegalovirus infection 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
8 | Human papillomavirus infection 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
9 | IL-17 signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
10 | JAK-STAT signaling pathway 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
11 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
12 | Leishmaniasis 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
13 | Metabolic pathways 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
14 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
15 | Morphine addiction 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
16 | Neuroactive ligand-receptor interaction 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
17 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
18 | Nicotine addiction 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
19 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
20 | Oxytocin signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
21 | Pathways in cancer 2 genes, 2 drugs (DrugBank), 16 diseases shown |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
22 | PI3K-Akt signaling pathway 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] EPOR |
D03231 |
Erythropoietin |
[9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
23 | Platelet activation 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS1 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
24 | Regulation of lipolysis in adipocytes 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
25 | Retrograde endocannabinoid signaling 17 genes, 2 drugs (DrugBank), 15 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
26 | Serotonergic synapse 5 genes, 2 drugs (DrugBank), 15 diseases shown |
[3] GABRB1, GABRB2, GABRB3 |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
[2] PTGS1, PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
27 | Small cell lung cancer 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
28 | Taste transduction 6 genes, 1 drug (DrugBank), 8 diseases shown |
[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
29 | TNF signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |
30 | VEGF signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] PTGS2 |
D00109 |
Acetylsalicylic acid |
[10] 13, 22, 34, 46, 49, 51, 86, 113, 158, 231 |